Stereotaxis (STXS) Enterprise Value (2010 - 2026)
Stereotaxis (STXS) posted quarterly Enterprise Value of -$14.6 million for Q1 2026, down 36.74% year-over-year from -$23.1 million in Q1 2025, and down 8.9% quarter-over-quarter from -$13.4 million in Q4 2025.
Stereotaxis (STXS) Enterprise Value (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Enterprise Value for 17 consecutive years, with -$14.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value fell 36.74% year-over-year to -$14.6 million; the TTM figure through Mar 2026 stood at -$14.6 million (down 36.74% YoY), while the FY2025 annual figure was -$13.4 million, down 7.92% from the prior year.
- Enterprise Value eased to -$14.6 million in Q1 2026 per STXS's latest filing, from -$13.4 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$7.0 million in Q2 2025 and bottomed at -$49.5 million in Q4 2022.
- Historically, Enterprise Value has averaged -$20.3 million across 5 years, with a median of -$15.6 million in 2024.
- Annual changes were most pronounced in 2023 — Enterprise Value jumped 80.56% — and 2024, when it sank 157.67%.
- Stereotaxis' Enterprise Value stood at -$49.5 million in 2022, then jumped by 57.44% to -$21.1 million in 2023, then surged by 41.03% to -$12.4 million in 2024, then decreased by 7.92% to -$13.4 million in 2025, then retreated by 8.9% to -$14.6 million in 2026.
- Business Quant data shows STXS's Enterprise Value at -$14.6 million in Q1 2026, -$13.4 million in Q4 2025, and -$10.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.86 Bn | 129.64 Bn | 1.96 Bn | -5.09 Bn |
| 2 | Becton Dickinson | 52.52 Bn | 51.66 Bn | 2.32 Bn | -863.00 Mn |
| 3 | Alcon | 35.73 Bn | 34.38 Bn | 1.68 Bn | -1.36 Bn |
| 4 | Resmed | 34.00 Bn | 32.53 Bn | 861.22 Mn | -1.47 Bn |
| 5 | Medline | 29.17 Bn | 26.49 Bn | 2.22 Bn | 4.83 Bn |
| 6 | West Pharmaceutical Services | 24.80 Bn | 24.37 Bn | 329.20 Mn | -435.80 Mn |
| 7 | Solventum | 15.29 Bn | 14.89 Bn | 1.29 Bn | -403.00 Mn |
| 8 | Cooper Companies | 14.84 Bn | 14.70 Bn | 735.40 Mn | -138.60 Mn |
| 9 | Baxter International | 13.64 Bn | 11.49 Bn | 1.03 Bn | -2.18 Bn |
| 10 | Stereotaxis | 143.29 Mn | 128.68 Mn | 3.79 Mn | -14.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.62 Mn |
| Dec 31, 2025 | -13.42 Mn |
| Sep 30, 2025 | -10.51 Mn |
| Jun 30, 2025 | -6.97 Mn |
| Mar 31, 2025 | -10.69 Mn |
| Dec 31, 2024 | -12.44 Mn |
| Sep 30, 2024 | -11.01 Mn |
| Jun 30, 2024 | -15.65 Mn |
| Mar 31, 2024 | -18.77 Mn |
| Dec 31, 2023 | -21.09 Mn |
| Sep 30, 2023 | -22.63 Mn |
| Jun 30, 2023 | -24.50 Mn |
| Mar 31, 2023 | -7.29 Mn |
| Dec 31, 2022 | -49.54 Mn |
| Sep 30, 2022 | -33.05 Mn |
| Jun 30, 2022 | -35.74 Mn |
| Mar 31, 2022 | -37.47 Mn |
| Dec 31, 2021 | -40.60 Mn |
| Sep 30, 2021 | -41.85 Mn |
| Jun 30, 2021 | -43.54 Mn |